530 related articles for article (PubMed ID: 38203531)
1. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.
Saramowicz K; Siwecka N; Galita G; Kucharska-Lusina A; Rozpędek-Kamińska W; Majsterek I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203531
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
[TBL] [Abstract][Full Text] [Related]
3. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology of α-synuclein in Parkinson's disease.
Choong CJ; Mochizuki H
Neuropathology; 2022 Apr; 42(2):93-103. PubMed ID: 35362115
[TBL] [Abstract][Full Text] [Related]
6. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
Boi L; Pisanu A; Palmas MF; Fusco G; Carboni E; Casu MA; Satta V; Scherma M; Janda E; Mocci I; Mulas G; Ena A; Spiga S; Fadda P; De Simone A; Carta AR
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198335
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
Olsen AL; Feany MB
Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
[TBL] [Abstract][Full Text] [Related]
9. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.
Hu D; Sun X; Liao X; Zhang X; Zarabi S; Schimmer A; Hong Y; Ford C; Luo Y; Qi X
Acta Neuropathol; 2019 Jun; 137(6):939-960. PubMed ID: 30877431
[TBL] [Abstract][Full Text] [Related]
11. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.
Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L
Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective.
Yi S; Wang L; Wang H; Ho MS; Zhang S
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080
[TBL] [Abstract][Full Text] [Related]
13. Rab7 reduces α-synuclein toxicity in rats and primary neurons.
Szegö EM; Van den Haute C; Höfs L; Baekelandt V; Van der Perren A; Falkenburger BH
Exp Neurol; 2022 Jan; 347():113900. PubMed ID: 34695425
[TBL] [Abstract][Full Text] [Related]
14. STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.
Hinkle JT; Patel J; Panicker N; Karuppagounder SS; Biswas D; Belingon B; Chen R; Brahmachari S; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2118819119. PubMed ID: 35394877
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.
Graves NJ; Gambin Y; Sierecki E
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569510
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype.
Yildirim-Balatan C; Fenyi A; Besnault P; Gomez L; Sepulveda-Diaz JE; Michel PP; Melki R; Hunot S
J Neuroinflammation; 2024 Feb; 21(1):54. PubMed ID: 38383421
[TBL] [Abstract][Full Text] [Related]
17. Immunological features of alpha-synuclein in Parkinson's disease.
Roodveldt C; Christodoulou J; Dobson CM
J Cell Mol Med; 2008 Oct; 12(5B):1820-9. PubMed ID: 18671754
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides, α-Synuclein, and Parkinson's Disease.
Ledeen RW; Wu G
Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
[TBL] [Abstract][Full Text] [Related]
19. Neurons and Glia Interplay in α-Synucleinopathies.
Mavroeidi P; Xilouri M
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066733
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss.
Ho DH; Nam D; Seo M; Park SW; Seol W; Son I
Cells; 2022 Mar; 11(5):. PubMed ID: 35269482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]